BANK OF MONTREAL /CAN/ - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2022$10,910,247
+63.0%
1,707,394
+152.0%
0.01%
+66.7%
Q3 2022$6,694,000
+74.4%
677,579
+194.9%
0.00%
+50.0%
Q1 2022$3,839,000
+52.9%
229,734
+78.0%
0.00%
+100.0%
Q4 2021$2,510,000
-29.3%
129,063
-3.7%
0.00%
-50.0%
Q2 2021$3,550,000
+2529.6%
134,046
+3021.0%
0.00%
Q1 2021$135,000
-20.1%
4,295
+30.1%
0.00%
Q4 2020$169,000
+207.3%
3,301
+69.5%
0.00%
Q3 2020$55,000
-6.8%
1,948
+0.8%
0.00%
Q2 2020$59,000
-75.4%
1,933
-76.7%
0.00%
Q1 2020$240,000
-44.4%
8,313
-46.8%
0.00%
Q4 2019$432,000
+92.0%
15,632
+26.1%
0.00%
Q3 2019$225,000
-23.2%
12,394
+3.8%
0.00%
Q2 2019$293,000
+1231.8%
11,937
+410.6%
0.00%
Q1 2019$22,000
-33.3%
2,338
-39.0%
0.00%
Q4 2018$33,000
+3.1%
3,833
+31.9%
0.00%
Q3 2018$32,000
-36.0%
2,905
-25.9%
0.00%
Q2 2018$50,000
-10.7%
3,922
+17.5%
0.00%
Q1 2018$56,000
+700.0%
3,338
+298.3%
0.00%
Q4 2017$7,000
-36.4%
838
-38.5%
0.00%
Q3 2017$11,000
+83.3%
1,363
+62.6%
0.00%
Q2 2017$6,0008380.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders